Treatment of the Common Cold
Am Fam Physician. 2019 Sep 1;100(5):281-289.
Patient information: See related handouts on treating common colds in adults and treating common colds in children, written by the authors of this article.
Author disclosure: No relevant financial affiliations.
Article Sections
Acute upper respiratory tract infections are extremely common in adults and children, but only a few safe and effective treatments are available. Patients typically present with nasal congestion, rhinorrhea, sore throat, cough, general malaise, and/or low-grade fever. Informing patients about the self-limited nature of the common cold can help manage expectations, limit antibiotic use, and avoid over-the-counter purchases that may not help. Treatments with proven effectiveness for cold symptoms in adults include over-the-counter analgesics, zinc, nasal decongestants with or without antihistamines, and ipratropium for cough. Lower-quality evidence suggests that Lactobacillus casei may be beneficial in older adults. The only established safe and effective treatments for children are acetylcysteine, honey (for children one year and older), nasal saline irrigation, intranasal ipratropium, and topical application of ointment containing camphor, menthol, and eucalyptus oils. Over-the-counter cold medications should not be used in children younger than four years. Counseling patients about the importance of good hand hygiene is the best way to prevent transmission of cold viruses.
Acute upper respiratory tract infection (URI), also called the common cold, is the most common acute illness in the United States and the industrialized world.1 Patients typically present with nasal congestion, rhinorrhea, sore throat, cough, general malaise, and/or low-grade fever. Symptoms are self-limited, often lasting up to 10 days. In children, the median duration is eight days in those who receive medical care, and 90% of cases resolve within 23 days.2 Viruses such as rhinovirus are the predominant cause of acute URI; transmission occurs through contact with the nasal secretions and saliva of infected people.3 The common cold should be distinguished from allergic rhinitis, isolated pharyngitis, acute bronchitis (which generally has a longer duration, with a mean of 18 days in adults and 12 days in children2,4 ), influenza, bacterial sinusitis, and pertussis (Table 1). The primary goals of treatment are reduction of symptom duration and severity. Over-the-counter cold medications should not be used to treat children younger than four years because of lack of benefit and low but significant mortality rates associated with their use in this population.5,6 Informing patients about the natural course of the common cold can help manage expectations, limit antibiotic use,7 and avoid unnecessary over-the-counter purchases (Table 2).
SORT: KEY RECOMMENDATIONS FOR PRACTICE
RCT = randomized controlled trial.
A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.
SORT: KEY RECOMMENDATIONS FOR PRACTICE
RCT = randomized controlled trial.
A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.
BEST PRACTICES IN INFECTIOUS DISEASES
Recommendations from the Choosing Wisely Campaign
| Recommendation | Sponsoring organization |
|---|---|
Antibiotics should not be used for apparent viral respiratory illnesses (sinusitis, pharyngitis, bronchitis). | American Academy of Pediatrics |
Avoid prescribing antibiotics for upper respiratory infections. | Infectious Diseases Society of America |
Source: For more information on the Choosing Wisely Campaign, see https://www.choosingwisely.org. For supporting citations and to search Choosing Wisely recommendations relevant to primary care, see https://www.aafp.org/afp/recommendations/search.htm.
BEST PRACTICES IN INFECTIOUS DISEASES
Recommendations from the Choosing Wisely Campaign
| Recommendation | Sponsoring organization |
|---|---|
Antibiotics should not be used for apparent viral respiratory illnesses (sinusitis, pharyngitis, bronchitis). | American Academy of Pediatrics |
Avoid prescribing antibiotics for upper respiratory infections. | Infectious Diseases Society of America |
Source: For more information on the Choosing Wisely Campaign, see https://www.choosingwisely.org. For supporting citations and to search Choosing Wisely recommendations relevant to primary care, see https://www.aafp.org/afp/recommendations/search.htm.
Differential Diagnosis for the Common Cold
| Diagnosis | Symptom onset | Cough | Sore throat | Fever | Rhinorrhea | Aches | Watery eyes | Sneezing | Nasal congestion | Headache | Shortness of breath |
|---|---|---|---|---|---|---|---|---|---|---|---|
Acute bronchitis | Gradual | Prominent, persistent, dry or wet | Common | None or low grade | Uncommon | Mild | Common | Uncommon | Uncommon | Common, mild | Common |
Allergic rhinitis | Gradual | Common, chronic | Possible, especially on awakening | None | Common, prominent | None | Common | Prominent | Common | Uncommon | Uncommon |
Bacterial sinusitis | Gradual | Common | Common | Common | Common | Common | Uncommon | Uncommon | Common | Common | Uncommon |
Common cold | Gradual | Common, dry | Common | None or low grade | Common | Mild | Common | Common | Common | Common, mild | Uncommon |
Influenza | Abrupt | Common, dry hacking | Common | Characteristic; high and rises rapidly | Common | Early, prominent | Uncommon | Uncommon | Possible | Prominent | Uncommon |
Pertussis | Gradual | Prominent, paroxysmal, whoop-like | Uncommon | None or low grade | Uncommon | Uncommon | Uncommon | Uncommon | Uncommon | Uncommon | Common |
Pharyngitis | Gradual | Uncommon | Characteristic; prominent | Variable (low grade if viral, high if bacterial) | Common | Can be severe if bacterial | Common | Common if viral | Uncommon | Common; mild if viral, severe if bacterial | Uncommon |
Differential Diagnosis for the Common Cold
| Diagnosis | Symptom onset | Cough | Sore throat | Fever | Rhinorrhea | Aches | Watery eyes | Sneezing | Nasal congestion | Headache | Shortness of breath |
|---|---|---|---|---|---|---|---|---|---|---|---|
Acute bronchitis | Gradual | Prominent, persistent, dry or wet | Common | None or low grade | Uncommon | Mild | Common | Uncommon | Uncommon | Common, mild | Common |
Allergic rhinitis | Gradual | Common, chronic | Possible, especially on awakening | None | Common, prominent | None | Common | Prominent | Common | Uncommon | Uncommon |
Bacterial sinusitis | Gradual | Common | Common | Common | Common | Common | Uncommon | Uncommon | Common | Common | Uncommon |
Common cold | Gradual | Common, dry | Common | None or low grade | Common | Mild | Common | Common | Common | Common, mild | Uncommon |
Influenza | Abrupt | Common, dry hacking | Common | Characteristic; high and rises rapidly | Common | Early, prominent | Uncommon | Uncommon | Possible | Prominent | Uncommon |
Pertussis | Gradual | Prominent, paroxysmal, whoop-like | Uncommon | None or low grade | Uncommon | Uncommon | Uncommon | Uncommon | Uncommon | Uncommon | Common |
Pharyngitis | Gradual | Uncommon | Characteristic; prominent | Variable (low grade if viral, high if bacterial) | Common | Can be severe if bacterial | Common | Common if viral | Uncommon | Common; mild if viral, severe if bacterial | Uncommon |
Managing Discussions with Patients About Unnecessary Antibiotics
| Step | Examples |
|---|---|
Explain why antibiotics will not help | “The common cold is caused by a virus, so antibiotics won't help.” |
“Antibiotics can't fight viruses like colds. Taking them won't do any good this time and may hurt their chances of fighting bacterial infections you might get in the future.” | |
Suggest treatments that might help | “You can try honey for your cough, ibuprofen or acetaminophen for your muscle aches, and nasal or oral decongestants with or without an antihistamine for your congestion.” |
Manage expectations for length of illness | “Cold viruses can make you feel lousy. Most people start to feel better after about a week, but sometimes the cough can last even longer, especially if you smoke.” |
“It is common for children and adults (especially those around young children) to seem sick throughout the entire fall and winter. You can catch one cold virus right after another, like planes taking off at a busy airport. The good news is that you should not get those same viruses again.” | |
Discuss next steps if patient does not improve | “If you develop worsening symptoms like a fever higher than 101°F (38.3°C), productive cough, shortness of breath, or very bad headache or facial pain, call my office so we can make sure you don't have a more serious illness.” |
Managing Discussions with Patients About Unnecessary Antibiotics
| Step | Examples |
|---|---|
Explain why antibiotics will not help | “The common cold is caused by a virus, so antibiotics won't help.” |
“Antibiotics can't fight viruses like colds. Taking them won't do any good this time and may hurt their chances of fighting bacterial infections you might get in the future.” | |
Suggest treatments that might help | “You can try honey for your cough, ibuprofen or acetaminophen for your muscle aches, and nasal or oral decongestants with or without an antihistamine for your congestion.” |
Manage expectations for length of illness | “Cold viruses can make you feel lousy. Most people start to feel better after about a week, but sometimes the cough can last even longer, especially if you smoke.” |
“It is common for children and adults (especially those around young children) to seem sick throughout the entire fall and winter. You can catch one cold virus right after another, like planes taking off at a busy airport. The good news is that you should not get those same viruses again.” | |
Discuss next steps if patient does not improve | “If you develop worsening symptoms like a fever higher than 101°F (38.3°C), productive cough, shortness of breath, or very bad headache or facial pain, call my office so we can make sure you don't have a more serious illness.” |
Prevention
Good hand hygiene is the most effective and practical way to prevent URIs in children and adults.8 The use of hand sanitizer is more protective than hand washing and is associated with shorter duration of symptoms and fewer school absences.9,10 Washing hands several times per day for at least 15 to 30 seconds can help prevent illness.8,11,12 Regular soap is as effective as antibacterial soap.13
Interventions with limited or no effectiveness for the prevention of the common cold include ginseng and echinacea,14 adenovirus vaccination,15 vitamin C or D,16–19 probiotics,20 and water gargles.21
Treatment for Adults
EFFECTIVE SYMPTOMATIC TREATMENTS
Effective treatments for symptoms of the common cold in adults are limited to intranasal ipratropium (Atrovent), over-the-counter analgesics, decongestants with or without antihistamines, and zinc (Table 3).22–30
Effective Treatments for Cold Symptoms in Adults
| Treatment | Dosing | Duration of treatment | Study findings |
|---|---|---|---|
Acetaminophen | 500 to 1,000 mg | Single dose | Cochrane review without data pooling of 4 low- to moderate-quality trials with outcome assessment at 3 to 6 hours found improvement in nasal obstruction and rhinorrhea but not in other symptoms; no numeric data provided22 |
Antihistamine plus decongestant | Varies | Variable | Cochrane review of 12 trials, including 6 placebo controlled with pooled data, found odds ratio of treatment failure = 0.27 (95% CI, 0.15 to 0.50); number needed to treat = 4, but 41% favorable response in placebo group23 |
Inhaled ipratropium (Atrovent) | 4 20-g puffs 4 times per day | 3 weeks | One small, randomized, double-blind crossover trial (N = 14) found significant reduction in persistent cough24 |
Intranasal oxymetazoline | 2 sprays (0.05%) per nostril 1 or 2 times per day | Up to 10 days | Cochrane review of 15 trials (N = 1,838) found no improvement in nasal congestion with single use, but small improvement vs. placebo after multiple doses (SMD = 0.49; 95% CI, 0.07 to 0.92)25 |
Lactobacillus casei (for older adults) | 200 g per day of fermented dairy product containing L. casei | 3 months | RCT of 1,072 older adults found significant improvement in duration of colds and in cumulative days with colds when taken daily26 |
Nonsteroidal anti-inflammatory drugs | Varies | Varies from single dose to 7 days | Cochrane review of 9 moderate-quality RCTs (N = 1,069) found no effect on total symptom score or cough, but improved sneezing (SMD = −0.44; 95% CI, −0.75 to −0.12), headache (SMD = −0.65; 95% CI, −1.11 to −0.19), and ear, muscle, and joint pain (SMD = −0.40; 95% CI, −0.77 to −0.03) vs. placebo27 |
Zinc acetate or gluconate | Varies; typically 80 to 92 mg per day | Start within 3 days of symptom onset and continue as long as symptoms persist | 3 systematic reviews and meta-analyses found similar improvement in symptom duration (by about one-third) and mixed conclusions on symptom severity 28–30 |
Effective Treatments for Cold Symptoms in Adults
| Treatment | Dosing | Duration of treatment | Study findings |
|---|---|---|---|
Acetaminophen | 500 to 1,000 mg | Single dose | Cochrane review without data pooling of 4 low- to moderate-quality trials with outcome assessment at 3 to 6 hours found improvement in nasal obstruction and rhinorrhea but not in other symptoms; no numeric data provided22 |
Antihistamine plus decongestant | Varies | Variable | Cochrane review of 12 trials, including 6 placebo controlled with pooled data, found odds ratio of treatment failure = 0.27 (95% CI, 0.15 to 0.50); number needed to treat = 4, but 41% favorable response in placebo group23 |
Inhaled ipratropium (Atrovent) | 4 20-g puffs 4 times per day | 3 weeks | One small, randomized, double-blind crossover trial (N = 14) found significant reduction in persistent cough24 |
Intranasal oxymetazoline | 2 sprays (0.05%) per nostril 1 or 2 times per day | Up to 10 days | Cochrane review of 15 trials (N = 1,838) found no improvement in nasal congestion with single use, but small improvement vs. placebo after multiple doses (SMD = 0.49; 95% CI, 0.07 to 0.92)25 |
Lactobacillus casei (for older adults) | 200 g per day of fermented dairy product containing L. casei | 3 months | RCT of 1,072 older adults found significant improvement in duration of colds and in cumulative days with colds when taken daily26 |
Nonsteroidal anti-inflammatory drugs | Varies | Varies from single dose to 7 days | Cochrane review of 9 moderate-quality RCTs (N = 1,069) found no effect on total symptom score or cough, but improved sneezing (SMD = −0.44; 95% CI, −0.75 to −0.12), headache (SMD = −0.65; 95% CI, −1.11 to −0.19), and ear, muscle, and joint pain (SMD = −0.40; 95% CI, −0.77 to −0.03) vs. placebo27 |
Zinc acetate or gluconate | Varies; typically 80 to 92 mg per day | Start within 3 days of symptom onset and continue as long as symptoms persist | 3 systematic reviews and meta-analyses found similar improvement in symptom duration (by about one-third) and mixed conclusions on symptom severity 28–30 |
Analgesics. Nonsteroidal anti-inflammatory drugs—mainly ibuprofen—have been shown to reduce headache, ear pain, muscle pain, joint pain, and sneezing but do not improve cough, cold duration, or total symptom score.27 Ibuprofen is more effective than acetaminophen for reducing fever-related discomfort.31 Acetaminophen may provide short-term relief of rhinorrhea and nasal obstruction but has no effect on sore throat, malaise, sneezing, or cough.22
Decongestants. Nasal decongestants (oral and intranasal) may relieve nasal congestion,25 but there is no evidence that they reduce cough. Topical oxymetazoline, which is included in many over-the-counter intranasal decongestants, reduces the duration and severity of nasal congestion after multiple doses.32 Patients should be warned about the risk of rhinitis when intranasal oxymetazoline is used for more than three days.33
Antihistamines in Combination Medications. Antihistamines combined with oral decongestants and/or analgesics may provide some relief of cold symptoms, although the effect on cough is limited.6,23 This benefit is most pronounced in the first two days of treatment.34 When started on the first day of symptoms, medications containing ibuprofen and pseudoephedrine may reduce the severity of cold symptoms.35 Antihistamine monotherapy is not effective for relieving cough.6,23
Ipratropium. Intranasal ipratropium is the only medication that improves persistent cough related to URI in adults.24,36 Inhaled ipratropium in combination with albuterol improves cough during the first 10 days of treatment, but there is no benefit at 20 days compared with placebo.37
Complementary and Alternative Treatments. Several meta-analyses and a randomized controlled trial suggest that taking at least 75 mg of zinc acetate or gluconate lozenges per day relieves cough and nasal discharge more quickly when treatment is started within 24 hours of symptom onset.28–30,38 Probiotics may have a role in the treatment of URIs. A randomized controlled trial showed that three months of daily use of a fermented dairy product containing Lactobacillus casei reduced the duration of URI symptoms by 1.5 days in older adults.26
TREATMENTS WITH UNCERTAIN BENEFIT
Although nasal saline irrigation is effective for the treatment of chronic rhinosinusitis, only low-quality evidence supports its benefit in URIs.39 Increased fluid intake is commonly recommended, but low-quality data suggest that it may not provide benefit and in rare cases can cause hyponatremia.40 Good evidence is similarly lacking for acetylcysteine,41 garlic,42,43 and Chinese medicinal herbs.44,45
INEFFECTIVE TREATMENTS
There are more ineffective treatments for the common cold than effective treatments, and some may even be harmful (Table 4).6,16,19,34,46–54 Treatments that are not recommended include antibiotics, antivirals, most cough medications, antihistamine monotherapy, intranasal corticosteroids, steam, vitamins D and E, echinacea, and Pelargonium sidoides (African geranium).
Ineffective Treatments for Cold Symptoms in Adults
| Treatment | Study type | Findings |
|---|---|---|
Antibiotics | No benefit for symptom duration or severity compared with no antibiotics or placebo | |
Antihistamine monotherapy (sedating and nonsedating) | No more effective than placebo for global improvement | |
Antitussives and expectorants* | Cochrane review of 10 trials without meta-analysis6 | No more effective than placebo for cough |
Codeine | Older RCT of 82 adults48 | No more effective than placebo for cough |
Echinacea | Cochrane review of 24 RCTs without meta-analysis49 | No more effective than placebo for reducing symptom duration or severity |
Intranasal corticosteroids | Cochrane review of 3 RCTs50 | No more effective than placebo for reducing symptom duration or severity |
Pelargonium sidoides (African geranium) | Cochrane review of a low-quality trial51 | No significant improvement by day 5 |
Steam | Cochrane review of 6 trials with 387 participants52 | No benefit of using heated humidified air for treatment of URIs |
Vitamin C | Cochrane review of 29 RCTs16 | No more effective than placebo for reducing symptom duration or severity once symptoms have developed |
Vitamin D | RCT of 322 adults19 | No difference in URI occurrence, days of missed work, or symptom duration or severity with high-dose vitamin D supplementation (200,000 IU followed by 100,000 IU monthly) |
Vitamin E | RCT of 652 adults 60 years and older 53 | Significantly worse URI symptoms with daily supplementation of vitamin E (200 mg) compared with no supplementation; no difference in URI occurrence |
Ineffective Treatments for Cold Symptoms in Adults
| Treatment | Study type | Findings |
|---|---|---|
Antibiotics | No benefit for symptom duration or severity compared with no antibiotics or placebo | |
Antihistamine monotherapy (sedating and nonsedating) | No more effective than placebo for global improvement | |
Antitussives and expectorants* | Cochrane review of 10 trials without meta-analysis6 | No more effective than placebo for cough |
Codeine | Older RCT of 82 adults48 | No more effective than placebo for cough |
Echinacea | Cochrane review of 24 RCTs without meta-analysis49 | No more effective than placebo for reducing symptom duration or severity |
Intranasal corticosteroids | Cochrane review of 3 RCTs50 | No more effective than placebo for reducing symptom duration or severity |
Pelargonium sidoides (African geranium) | Cochrane review of a low-quality trial51 | No significant improvement by day 5 |
Steam | Cochrane review of 6 trials with 387 participants52 | No benefit of using heated humidified air for treatment of URIs |
Vitamin C | Cochrane review of 29 RCTs16 | No more effective than placebo for reducing symptom duration or severity once symptoms have developed |
Vitamin D | RCT of 322 adults19 | No difference in URI occurrence, days of missed work, or symptom duration or severity with high-dose vitamin D supplementation (200,000 IU followed by 100,000 IU monthly) |
Vitamin E | RCT of 652 adults 60 years and older 53 | Significantly worse URI symptoms with daily supplementation of vitamin E (200 mg) compared with no supplementation; no difference in URI occurrence |
Antibiotics. Antibiotics have no role in the treatment of the common cold. They do not reduce the severity or duration of symptoms, even when purulent rhinitis is present.46,47 Antibiotic prescriptions for patients with URI are a major source of inappropriate prescribing in the outpatient setting.55 Informing patients about the natural course of URIs and recommending appropriate treatments will improve antibiotic stewardship in the United States.7
Antihistamine Monotherapy. When used alone, antihistamines are no more effective than placebo for the treatment of cold symptoms.6,34
Antitussives and Expectorants. Antitussives and expectorants have little benefit in the treatment of cough due to the common cold.6,54 Codeine and other opioid antitussives have not been studied extensively for the treatment of acute cough in adults.6 One trial of 82 adults found that codeine was no more effective than placebo for cough; however, both groups had significant reductions in cough frequency and severity during the first two days of treatment.48
Antivirals. Antivirals are not indicated or effective for the treatment of URIs, and they have been associated with clinical syndromes similar to the common cold. Because of their effectiveness in preventing other conditions, several antivirals (e.g., interferons, dipyridamole [Persantine], palmitate) have been studied for the treatment of URIs. However, no benefit was found, and none are licensed for this use.
Intranasal Corticosteroids. Three small trials found no evidence that intranasal corticosteroids relieve symptoms of the common cold.50
Complementary and Alternative Treatments. Neither steam31,56 nor vitamin D supplementation 19 improves symptoms of the common cold. Once symptoms have developed, vitamin C has no effect on symptom duration or severity.16 Vitamin E can actually make symptoms worse in older adults.53 Although echinacea was previously thought to provide benefit, high-quality studies have not shown that it reduces the duration or severity of cold symptoms.49,52,57,58 Based on low-quality evidence, P. sidoides does not shorten time to resolution of cold symptoms in adults.51
Children
Safe and effective treatment options for symptoms of the common cold in children vary somewhat from those for adults. Nasal saline irrigation, analgesics, and time are the mainstays of treatment for URIs in children. Other effective treatments are summarized in Table 5.6,16,41,59–64
Effective Treatments for Cold Symptoms in Children
| Treatment | Age of participants | Dosing | Duration of treatment | Study findings |
|---|---|---|---|---|
Acetylcysteine | 0 to 18 years | Varies | Variable, up to 28 days | Cochrane review of 6 low- to moderate-quality trials (N = 497) found small reduction in cough at day 7 vs. placebo41 |
Analgesics | 0 to 18 years | Acetaminophen: 15 mg per kg | Variable during symptoms | Cochrane review of 6 low- to moderate-quality studies (N = 915) found that acetaminophen and/or ibuprofen lowers temperature and may result in less discomfort59 |
Ibuprofen: 5 to 10 mg per kg | ||||
Honey | 2 to 5 years | 2.5 mL | Once | 2 Cochrane reviews and 1 RCT found significant reduction in symptoms6,60,61 |
6 to 11 years | 5 mL | Once | ||
12 to 18 years | 10 mL | Once | ||
Intranasal ipratropium (Atrovent) | 5 to 11 years | 2 sprays (0.03% or 0.6%) per nostril 3 or 4 times per day | First 2 to 3 days of symptoms | Cochrane review of 7 RCTs (N = 2,144) without meta-analysis showed significant reduction in rhinorrhea but not nasal congestion vs. placebo62 |
Nasal saline irrigation | 6 to 10 years | 3 to 9 mL per nostril | Up to 3 weeks | RCT (N = 401) showed improved resolution of nasal symptoms; reduced use of antipyretics, mucolytics, and antibiotics; and fewer days missed from school (P < .05 for all)63 |
Ointment containing camphor, menthol, and eucalyptus oils | 2 to 5 years | 5 mL | Once | RCT (N = 138) found reduced cough, congestion, and sleep difficulty compared with petrolatum ointment or no treatment (P < .05 for all)64 |
6 to 11 years | 10 mL | Once | ||
Vitamin C | 0 to 18 years | 1 to 2 g daily | 40 days to 28 weeks (typically about 3 months) | Cochrane review of 29 trials found no benefit for preventing colds, but reduced symptom duration by 18% (about 1 to 2 days); starting vitamin C supplementation after symptom onset does not reduce symptom duration16 |
Effective Treatments for Cold Symptoms in Children
| Treatment | Age of participants | Dosing | Duration of treatment | Study findings |
|---|---|---|---|---|
Acetylcysteine | 0 to 18 years | Varies | Variable, up to 28 days | Cochrane review of 6 low- to moderate-quality trials (N = 497) found small reduction in cough at day 7 vs. placebo41 |
Analgesics | 0 to 18 years | Acetaminophen: 15 mg per kg | Variable during symptoms | Cochrane review of 6 low- to moderate-quality studies (N = 915) found that acetaminophen and/or ibuprofen lowers temperature and may result in less discomfort59 |
Ibuprofen: 5 to 10 mg per kg | ||||
Honey | 2 to 5 years | 2.5 mL | Once | 2 Cochrane reviews and 1 RCT found significant reduction in symptoms6,60,61 |
6 to 11 years | 5 mL | Once | ||
12 to 18 years | 10 mL | Once | ||
Intranasal ipratropium (Atrovent) | 5 to 11 years | 2 sprays (0.03% or 0.6%) per nostril 3 or 4 times per day | First 2 to 3 days of symptoms | Cochrane review of 7 RCTs (N = 2,144) without meta-analysis showed significant reduction in rhinorrhea but not nasal congestion vs. placebo62 |
Nasal saline irrigation | 6 to 10 years | 3 to 9 mL per nostril | Up to 3 weeks | RCT (N = 401) showed improved resolution of nasal symptoms; reduced use of antipyretics, mucolytics, and antibiotics; and fewer days missed from school (P < .05 for all)63 |
Ointment containing camphor, menthol, and eucalyptus oils | 2 to 5 years | 5 mL | Once | RCT (N = 138) found reduced cough, congestion, and sleep difficulty compared with petrolatum ointment or no treatment (P < .05 for all)64 |
6 to 11 years | 10 mL | Once | ||
Vitamin C | 0 to 18 years | 1 to 2 g daily | 40 days to 28 weeks (typically about 3 months) | Cochrane review of 29 trials found no benefit for preventing colds, but reduced symptom duration by 18% (about 1 to 2 days); starting vitamin C supplementation after symptom onset does not reduce symptom duration16 |
EFFECTIVE SYMPTOMATIC TREATMENTS
Analgesics. Although ibuprofen and acetaminophen reduce fever-related discomfort, ibuprofen may be more effective.59 Alternating these medications may reduce daycare absences in children with fever.
Acetylcysteine. The mucolytic acetylcysteine may safely decrease cough after six to seven days in children two years and older.41
Ipratropium. Intranasal ipratropium may decrease rhinorrhea but not congestion related to URIs in children five years and older. It should not be used in children younger than five years. The main adverse effects are nosebleeds, nasal dryness, and headache, although these are self-limited.62
Nasal Saline Irrigation. One large trial found that children who use saline nasal washes six times per day have faster resolution of nasal secretions and nasal obstruction and reduced use of antipyretics, decongestants, and antibiotics.63 This regimen also reduces school absences.
Complementary and Alternative Treatments. Application of ointment containing camphor, menthol, and eucalyptus oils on the chest and neck of children at bedtime can relieve nasal congestion and reduce nighttime cough frequency and severity, improving sleep for both the child and parents.64 The use of menthol alone may also improve perceived nasal patency but may not help with cough.65 Menthol is safe for use in children two years and older. The use of honey before bedtime may also reduce the frequency and severity of cough.60,61 Honey should not be given to children younger than 12 months because of the risk of exposure to botulinum spores.
TREATMENTS WITH UNCERTAIN BENEFIT
The use of antihistamines, either alone or in combination with a decongestant, is no more effective than placebo, and the risk of harm is significant.6 There is insufficient evidence on the use of oral or intranasal decongestants as monotherapy for symptoms of the common cold in children.25 Guaifenesin and other expectorants have not been studied in this population. P. sidoides may help with symptoms of acute bronchitis in children, but it has not been studied in children with the common cold.51 Two small trials demonstrated little or no clinically significant benefit of zinc in children, even with frequent doses that were started within 24 hours of symptom onset.66,67 A Cochrane review that previously reported benefit of zinc in children has been withdrawn.68
INEFFECTIVE TREATMENTS
Table 6 summarizes the evidence of ineffective treatments for children with the common cold.6,18,31,46,47,49,69
Ineffective Treatments for Cold Symptoms in Children
| Treatment | Study type | Findings |
|---|---|---|
Antibiotics | No benefit for symptom duration or severity compared with no antibiotics or placebo | |
Antihistamine monotherapy | Cochrane review of 3 RCTs6 | No more effective than placebo for cough |
Antihistamine plus decongestant | Cochrane review of 2 RCTs6 | No more effective than placebo for cough |
Antitussives | Cochrane review of 3 RCTs6 | No more effective than placebo for cough |
Antitussive plus bronchodilator | Cochrane review of RCTs6 | No more effective than placebo for cough |
Echinacea | Cochrane review of RCTs49 | No benefit for symptom severity, peak symptom severity, number of days of fever, or parental report of severity compared with placebo |
Intranasal corticosteroids | Cochrane review of 2 studies69 | No decrease in episodes requiring oral corticosteroids, emergency department visits, hospital admissions, frequency of wheezing, or duration of episodes |
Oral prednisolone | RCT of a 5-day course69 | No significant difference in duration of hospitalization, time from admission to discharge, mean 7-day symptom score reported by parent, or readmission for wheezing within 1 month compared with placebo |
Steam | RCT of adults and children with subgroup analysis of 200 children 3 to 16 years of age31 | No improvement in symptom severity with inhalation of steam for 5 minutes 3 times daily |
Vitamin D | RCT of 703 children 1 to 5 years of age18 | 2,000 IU of vitamin D did not reduce overall respiratory infections compared with 400 IU when taken daily for a minimum of 4 months |
Ineffective Treatments for Cold Symptoms in Children
| Treatment | Study type | Findings |
|---|---|---|
Antibiotics | No benefit for symptom duration or severity compared with no antibiotics or placebo | |
Antihistamine monotherapy | Cochrane review of 3 RCTs6 | No more effective than placebo for cough |
Antihistamine plus decongestant | Cochrane review of 2 RCTs6 | No more effective than placebo for cough |
Antitussives | Cochrane review of 3 RCTs6 | No more effective than placebo for cough |
Antitussive plus bronchodilator | Cochrane review of RCTs6 | No more effective than placebo for cough |
Echinacea | Cochrane review of RCTs49 | No benefit for symptom severity, peak symptom severity, number of days of fever, or parental report of severity compared with placebo |
Intranasal corticosteroids | Cochrane review of 2 studies69 | No decrease in episodes requiring oral corticosteroids, emergency department visits, hospital admissions, frequency of wheezing, or duration of episodes |
Oral prednisolone | RCT of a 5-day course69 | No significant difference in duration of hospitalization, time from admission to discharge, mean 7-day symptom score reported by parent, or readmission for wheezing within 1 month compared with placebo |
Steam | RCT of adults and children with subgroup analysis of 200 children 3 to 16 years of age31 | No improvement in symptom severity with inhalation of steam for 5 minutes 3 times daily |
Vitamin D | RCT of 703 children 1 to 5 years of age18 | 2,000 IU of vitamin D did not reduce overall respiratory infections compared with 400 IU when taken daily for a minimum of 4 months |
Antibiotics. Antibiotics provide no benefit for URI symptoms in terms of severity or duration.46,47 There is no role for antibiotics in the treatment of URIs in children.
Antitussives. Neither dextromethorphan nor codeine relieves cough in children with URIs.70,71
Bronchodilators. In a randomized controlled trial of 59 children without asthma, oral albuterol did not improve acute cough at seven days compared with placebo, but it was associated with increased adverse effects.72 Beta agonists have no benefit for cough in children without airflow restriction.72,73
Increased Fluid Intake. Low-quality studies suggest that increasing fluid intake in children with URIs actually causes harm.40
Intranasal and Oral Corticosteroids. Intranasal corticosteroids do not reduce symptom duration or severity in children with the common cold; oral corticosteroids have not been studied for the treatment of URIs in children.50,69
Complementary and Alternative Treatments. Steam does not improve cold symptoms in children, and caution must be used to prevent burns.31 Data do not support the use of vitamin D18 or echinacea49,74 in children with the common cold.
This article updates previous articles on this topic by Fashner, et al.,75 and by Simasek and Blandino.76
Data Sources: A primary search of PubMed, the Cochrane database, the TRIP database, clinical guidelines from the American College of Chest Physicians, the National Institute for Health and Clinical Excellence, DynaMed Plus, and Essential Evidence Plus was completed using the key words cold, cough, respiratory tract infection, upper respiratory infection, nasal congestion, and rhinorrhea. We also searched the U.S. Food and Drug Administration website for specific information regarding changes in recommendations for the use of cough and cold medications in children. Search dates: September 5 to November 28, 2018, and February 18 to July 17, 2019.
References
show all references1. Centers for Disease Control and Prevention. National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Accessed July 17, 2019. https://www.cdc.gov/nchs/data/series/sr_10/sr10_200.pdf...
2. Hay AD, Anderson E, Ingle S, et al. Respiratory tract infections in children in the community: prospective online inception cohort study. Ann Fam Med. 2019;17(1):14–22.
3. Kirkpatrick GL. The common cold. Prim Care. 1996;23(4):657–675.
4. Ebell MH, Lundgren J, Youngpairoj S. How long does a cough last? Comparing patients' expectations with data from a systematic review of the literature. Ann Fam Med. 2013;11(1):5–13.
5. U.S. Food Drug Administration. Use caution when giving cough and cold products to kids. Accessed November 21, 2018. https://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm263948.htm
6. Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014;(11):CD001831.
7. Centers for Disease Control and Prevention. Antibiotic use in the United States, 2017: progress and opportunities. Accessed June 19, 2019. https://www.cdc.gov/antibiotic-use/stewardship-report/pdf/stewardship-report.pdf
8. Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2011;(7):CD006207.
9. Hübner NO, Hübner C, Wodny M, et al. Effectiveness of alcohol-based hand disinfectants in a public administration: impact on health and work performance related to acute respiratory symptoms and diarrhoea. BMC Infect Dis. 2010;10:250.
10. Dyer DL, Shinder A, Shinder F. Alcohol-free instant hand sanitizer reduces elementary school illness absenteeism. Fam Med. 2000;32(9):633–638.
11. Chamberlain AN, Halablab MA, Gould DJ, et al. Distribution of bacteria on hands and the effectiveness of brief and thorough decontamination procedures using non-medicated soap. Zentralbl Bakteriol. 1997;285(4):565–575.
12. Todd EC, Michaels BS, Smith D, et al. Outbreaks where food workers have been implicated in the spread of foodborne disease. Part 9. Washing and drying of hands to reduce microbial contamination. J Food Prot. 2010;73(10):1937–1955.
13. Aiello AE, Coulborn RM, Perez V, et al. Effect of hand hygiene on infectious disease risk in the community setting: a meta-analysis. Am J Public Health. 2008;98(8):1372–1381.
14. Seida JK, Durec T, Kuhle S. North American (Panax quinquefolius) and Asian ginseng (Panax ginseng) preparations for prevention of the common cold in healthy adults: a systematic review. Evid Based Complement Alternat Med. 2011;2011:282151.
15. Simancas-Racines D, Franco JV, Guerra CV, et al. Vaccines for the common cold. Cochrane Database Syst Rev. 2017;(5):CD002190.
16. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;(1):CD000980.
17. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.
18. Aglipay M, Birken CS, Parkin PC, et al.; TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA. 2017;318(3):245–254.
19. Murdoch DR, Slow S, Chambers ST, et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA. 2012;308(13):1333–1339.
20. Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015;(2):CD006895.
21. Satomura K, Kitamura T, Kawamura T, et al.; Great Cold Investigators-I. Prevention of upper respiratory tract infections by gargling: a randomized trial. Am J Prev Med. 2005;29(4):302–307.
22. Li S, Yue J, Dong BR, et al. Acetaminophen (paracetamol) for the common cold in adults. Cochrane Database Syst Rev. 2013;(7):CD008800.
23. De Sutter AI, van Driel ML, Kumar AA, et al. Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochrane Database Syst Rev. 2012;(2):CD004976.
24. Holmes PW, Barter CE, Pierce RJ. Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection. Respir Med. 1992;86(5):425–429.
25. Deckx L, De Sutter AI, Guo L, et al. Nasal decongestants in monotherapy for the common cold. Cochrane Database Syst Rev. 2016;(10):CD009612.
26. Guillemard E, Tondu F, Lacoin F, et al. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr. 2010;103(1):58–68.
27. Kim SY, Chang YJ, Cho HM, et al. Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst Rev. 2015;(9):CD006362.
28. Hemilä H, Chalker E. The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis. BMC Fam Pract. 2015;16:24.
29. Hemilä H. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open. 2017;8(5):2054270417694291.
30. Science M, Johnstone J, Roth DE, et al. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials. CMAJ. 2012;184(10):E551–E561.
31. Little P, Moore M, Kelly J, et al.; PIPS Investigators. Ibuprofen, paracetamol, and steam for patients with respiratory tract infections in primary care: pragmatic randomised factorial trial. BMJ. 2013;347:f6041.
32. Reinecke S, Tschaikin M. Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis [in German]. MMW Fortschr Med. 2005;147(suppl 3):113–118.
33. Dykewicz MS, Fineman S, Skoner DP, et al.; American Academy of Allergy, Asthma, and Immunology. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998;81(5 pt 2):478–518.
34. DeSutter AI, Saraswat A, van Driel ML. Antihistamines for the common cold. Cochrane Database Syst Rev. 2015;(11):CD009345.
35. Klimek L, Schumacher H, Schütt T, et al. Factors associated with efficacy of an ibuprofen/pseudoephedrine combination drug in pharmacy customers with common cold symptoms. Int J Clin Pract. 2017;71(2):e12907.
36. Bolser DC. Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 suppl):238S–249S.
37. Zanasi A, Lecchi M, Del Forno M, et al. A randomized, placebo-controlled, double-blind trial on the management of post-infective cough by inhaled ipratropium and salbutamol administered in combination. Pulm Pharmacol Ther. 2014;29(2):224–232.
38. Prasad AS, Fitzgerald JT, Bao B, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;133(4):245–252.
39. King D, Mitchell B, Williams CP, et al. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015;(4):CD006821.
40. Guppy MP, Mickan SM, Del Mar CB, et al. Advising patients to increase fluid intake for treating acute respiratory infections. Cochrane Database Syst Rev. 2011;(2):CD004419.
41. Chalumeau M, Duijvestijn YC. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev. 2013;(5):CD003124.
42. Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. Adv Ther. 2001;18(4):189–193.
43. Lissiman E, Bhasale AL, Cohen M. Garlic for the common cold. Cochrane Database Syst Rev. 2014;(11):CD006206.
44. Li G, Cai L, Jiang H, et al. Compound formulas of traditional Chinese medicine for the common cold: systematic review of randomized, placebo-controlled trials. Altern Ther Health Med. 2015;21(6):48–57.
45. Zhang X, Wu T, Zhang J, et al. Chinese medicinal herbs for the common cold. Cochrane Database Syst Rev. 2007;(1):CD004782.
46. Spurling GK, Del Mar CB, Dooley L, et al. Delayed antibiotic prescriptions for respiratory infections. Cochrane Database Syst Rev. 2017;(9):CD004417.
47. Kenealy T, Arroll B. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2013;(6):CD000247.
48. Freestone C, Eccles R. Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol. 1997;49(10):1045–1049.
49. Karsch-Völk M, Barrett B, Kiefer D, et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2014;(2):CD000530.
50. Hayward G, Thompson MJ, Perera R, et al. Corticosteroids for the common cold. Cochrane Database Syst Rev. 2015;(10):CD008116.
51. Timmer A, Günther J, Motschall E, et al. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev. 2013;(10):CD006323.
52. Barrett BP, Brown RL, Locken K, et al. Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002;137(12):939–946.
53. Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA. 2002;288(6):715–721.
54. Malesker MA, Callahan-Lyon P, Ireland B, et al.; CHEST Expert Cough Panel. Pharmacologic and nonpharmacologic treatment for acute cough associated with the common cold. Chest. 2017;152(5):1021–1037.
55. Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA. 2016;315(17):1864–1873.
56. Singh M, Singh M, Jaiswal N, et al. Heated, humidified air for the common cold. Cochrane Database Syst Rev. 2017;(8):CD001728.
57. Woelkart K, Linde K, Bauer R. Echinacea for preventing and treating the common cold. Planta Med. 2008;74(6):633–637.
58. Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2004;164(11):1237–1241.
59. Wong T, Stang AS, Ganshorn H, et al. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Cochrane Database Syst Rev. 2013;(10):CD009572.
60. Paul IM, Beiler J, McMonagle A, et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med. 2007;161(12):1140–1146.
61. Oduwole O, Udoh EE, Oyo-Ita A, et al. Honey for acute cough in children. Cochrane Database Syst Rev. 2018;(4):CD007094.
62. AlBalawi ZH, Othman SS, Alfaleh K. Intranasal ipratropium bromide for the common cold. Cochrane Database Syst Rev. 2013;(6):CD008231.
63. Slapak I, Skoupá J, Strnad P, et al. Efficacy of isotonic nasal wash (sea-water) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg. 2008;134(1):67–74.
64. Paul IM, Beiler JS, King TS, et al. Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatrics. 2010;126(6):1092–1099.
65. Kenia P, Houghton T, Beardsmore C. Does inhaling menthol affect nasal patency or cough? Pediatr Pulmonol. 2008;43(6):532–537.
66. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother. 1984;25(1):20–24.
67. Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. JAMA. 1998;279(24):1962–1967.
68. Singh M, Das RR. Withdrawn: zinc for the common cold. Cochrane Database Syst Rev. 2015;(4):CD001364.
69. McKean M, Ducharme F. Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev. 2000;(2):CD001107.
70. Taylor JA, Novack AH, Almquist JR, et al. Efficacy of cough suppressants in children. J Pediatr. 1993;122(5 pt 1):799–802.
71. Paul IM, Yoder KE, Crowell KR, et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics. 2004;114(1):e85–e90.
72. Bernard DW, Goepp JG, Duggan AK, et al. Is oral albuterol effective for acute cough in non-asthmatic children? Acta Paediatr. 1999;88(4):465–467.
73. Becker LA, Hom J, Villasis-Keever M, et al. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. Cochrane Database Syst Rev. 2015;(9):CD001726.
74. Taylor JA, Weber W, Standish L, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA. 2003;290(21):2824–2830.
75. Fashner J, Ericson K, Werner S. Treatment of the common cold in children and adults. Am Fam Physician. 2012;86(2):153–159. Accessed June 19, 2019. https://www.aafp.org/afp/2012/0715/p153.html
76. Simasek M, Blandino DA. Treatment of the common cold. Am Fam Physician. 2007;75(4):515–520. Accessed June 19, 2019. https://www.aafp.org/afp/2007/0215/p515.html
Copyright © 2019 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact
afpserv@aafp.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions
More in AFP
Editor's Collections
Related Content
More in Pubmed
MOST RECENT ISSUE
Email Alerts
Don't miss a single issue. Sign up for the free AFP email table of contents.
